Sign In
Buy GSK
$51.46
-0.0700 (-0.136%)
At Close: Aug 05, 2026
Contact Levi & Korsinsky by April 7, 2025 Deadline to Join Class Action Against GSK plc (GSK)
10:25am, Friday, 07'th Feb 2025
NEW YORK, NY / ACCESS Newswire / February 7, 2025 / If you suffered a loss on your GSK plc (NYSE:GSK) investment and want to learn about a potential recovery under the federal securities laws, follow
Shareholders that lost money on GSK plc (GSK) should contact Levi & Korsinsky about pending Class Action - GSK
07:15am, Friday, 07'th Feb 2025
NEW YORK, NY / ACCESS Newswire / February 7, 2025 / If you suffered a loss on your GSK plc (NYSE:GSK) investment and want to learn about a potential recovery under the federal securities laws, follow
NEW YORK CITY, NY / ACCESS Newswire / February 7, 2025 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against GSK
GSK LAWSUIT ALERT: Levi & Korsinsky Notifies GSK plc Investors of a Class Action Lawsuit and Upcoming Deadline
08:15pm, Thursday, 06'th Feb 2025
NEW YORK, NY / ACCESS Newswire / February 6, 2025 / If you suffered a loss on your GSK plc (NYSE:GSK) investment and want to learn about a potential recovery under the federal securities laws, follow
GSK PLC Stockholder Notice: Shareholder Rights Law Firm Robbins LLP Reminds Investors of the Class Action Lawsuit Against GSK
07:48pm, Thursday, 06'th Feb 2025
SAN DIEGO, Feb. 06, 2025 (GLOBE NEWSWIRE) -- Robbins LLP reminds stockholders that a class action was filed on behalf of all purchasers of the American Depository Receipts ("ADRs") of GSK PLC (NYSE:
Class Action Filed Against GSK plc (GSK) Seeking Recovery for Investors – Contact Levi & Korsinsky
06:15pm, Thursday, 06'th Feb 2025
NEW YORK, NY / ACCESS Newswire / February 6, 2025 / If you suffered a loss on your GSK plc (NYSE:GSK) investment and want to learn about a potential recovery under the federal securities laws, follow
GSK Investors Have Opportunity to Lead GSK plc Securities Fraud Lawsuit with the Schall Law Firm
05:57pm, Thursday, 06'th Feb 2025
LOS ANGELES--(BUSINESS WIRE)--GSK Investors Have Opportunity to Lead GSK plc Securities Fraud Lawsuit with the Schall Law Firm.
GSK Investors Have Opportunity to Lead GSK plc Securities Fraud Lawsuit
03:21pm, Thursday, 06'th Feb 2025
NEW YORK , Feb. 6, 2025 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of American Depositary Receipts (
LOS ANGELES--(BUSINESS WIRE)--Glancy Prongay & Murray LLP, a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of GSK plc. (“GSK” or th
Bear Of The Day: GSK PLC (GSK)
08:11am, Thursday, 06'th Feb 2025
Healthcare stock investors have been feeling rather sick about the potential changes the Trump Administration may bring.
GSK Reported Strong Earnings, So I Reiterate My Strong Buy
08:00am, Thursday, 06'th Feb 2025
GSK's 2024 results are strong, with a promising shift toward specialty medicines, particularly in HIV, respiratory conditions, and cancer, driving long-term growth. Key drugs Blenrep and Depemokimab s
NEW YORK CITY, NY / ACCESS Newswire / February 6, 2025 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against GSK
GSK prelims get City thumbs up as investment banks upgrade
06:54am, Thursday, 06'th Feb 2025
UBS has raised its target price for GSK PLC (LSE:GSK, NYSE:GSK) from £15.80 to £16, following a better-than-expected full-year earnings report and a focus on improving shareholder returns. The pharm
GSK Tech Ecosystem Profile - Digital Transformation Strategies and Innovation Programs
04:02am, Thursday, 06'th Feb 2025
The report provides insights into GSK's tech activities, including its digital transformation strategies, its innovation programs, and its technology initiatives. The report provides insights into GSK
Investor Alert: Robbins LLP Informs Stockholders of the GSK PLC Class Action
07:54pm, Wednesday, 05'th Feb 2025
SAN DIEGO , Feb. 5, 2025 /PRNewswire/ -- Robbins LLP informs stockholders that a class action was filed on behalf of all purchasers of the American Depository Receipts ("ADRs") of GSK PLC (NYSE: GSK)
